Financials

  • Market Capitalization 87.1 M
  • Employee 76
  • Founded 2013
  • CEO Jayson Rieger
  • Website www.verrica.com
  • Headquarter Delaware, United States
  • FIGI BBG00L03BYB7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.95
Price to sales ratio
2.49

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3987
ICCC
ImmuCell Corporation - Common Stock
10.02 USD0.00%-0.69%-10.54%+59.30%91.00 M USD
3999
RLYB
Rallybio Corporation - Common Stock
16.76 USD-0.71%0.00%+3.46%+3003.70%89.00 M USD
4019
MAIA
MAIA Biotechnology, Inc. Common Stock
1.39 USD-1.42%0.00%+11.20%-33.17%84.55 M USD
4021
ACET
Adicet Bio, Inc. - Common Stock
9.01 USD+0.67%-4.35%+8.82%+1070.13%84.35 M USD

Frequently asked questions about Verrica Pharmaceuticals Inc. Common Stock

What is the Verrica Pharmaceuticals Inc. Common Stock stock price today?

The current price of Verrica Pharmaceuticals Inc. Common Stock (VRCA) is 5.07. Over the past 24 hours, the stock has changed by +3.26%. Follow the VRCA chart for real-time price dynamics.

What is the stock ticker of Verrica Pharmaceuticals Inc. Common Stock?

Verrica Pharmaceuticals Inc. Common Stock trades under the ticker VRCA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Verrica Pharmaceuticals Inc. Common Stock stock going up?

VRCA has changed by +3.47% over the last week, -5.23% over the last month, and -15.78% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Verrica Pharmaceuticals Inc. Common Stock?

Verrica Pharmaceuticals Inc. Common Stock currently has a market capitalization of 87.1 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Verrica Pharmaceuticals Inc. Common Stock earnings last quarter?

Last quarter, Verrica Pharmaceuticals Inc. Common Stock reported earnings of -0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Verrica Pharmaceuticals Inc. Common Stock revenue for the last quarter?

Verrica Pharmaceuticals Inc. Common Stock reported quarterly revenue of 5.86 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Verrica Pharmaceuticals Inc. Common Stock net income for the last quarter?

Verrica Pharmaceuticals Inc. Common Stock reported net income of -13.15 M for the last quarter. The previous quarter showed -9.68 M, which means net income changed by -35.85%.

How many employees does Verrica Pharmaceuticals Inc. Common Stock have?

As of the latest available data, Verrica Pharmaceuticals Inc. Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.

What is Verrica Pharmaceuticals Inc. Common Stock EBITDA?

Verrica Pharmaceuticals Inc. Common Stock EBITDA is -12.97 M, and its EBITDA margin is -221.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Verrica Pharmaceuticals Inc. Common Stock stock?

You can buy Verrica Pharmaceuticals Inc. Common Stock (VRCA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Verrica Pharmaceuticals Inc. Common Stock stock?

Investing in Verrica Pharmaceuticals Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRCA chart and related analysis on metatrader.com as part of your research.

News